At the end of August, Xero Ltd (ASX: XRO) shares were trading above $88. Today, you can pick them up 25% cheaper for $66.34. Xero shares have lost 17% in a month, 42% year to date, and collapsed 59% over 12 months.
For a tech stock once treated as an ASX growth darling, this is a stunning fall from grace.
Image source: Getty Images
A beating with no obvious trigger
Here's the strange part: there hasn't been a fresh earnings downgrade or a bombshell announcement behind this month's slide of Xero shares. The company's latest updates have mostly been routine substantial shareholder notices, and its FY26 result, released back in May, was actually pretty solid.
Revenue rose 31% to NZ$2.75 billion. Annualised monthly recurring revenue climbed 37% to NZ$3.27 billion. Subscribers grew 11% to 4.92 million. On the surface, this doesn't look like a business in trouble.
So what's spooking investors?
The market isn't looking at the top line, it's fixated on the risks underneath. Melio integration costs helped drag net profit down 27% to NZ$167.4 million, while gross margin slipped from 89% to 83.9%.
Add in broader questions about what AI could mean for software incumbents, plus lingering worries that elevated interest rates will keep punishing growth stocks, and you have a sell-off with plenty of narrative but not much hard news.
The growth case is still very much alive
Strip away the noise, and Xero added 506,000 customers over the year, lifting its global base to 4.92 million. Management isn't backing off either — FY27 guidance points to revenue of NZ$3.62 billion to NZ$3.73 billion, implying roughly 30% growth at the midpoint.
Xero's roots are in Australia and New Zealand, but the UK has grown into a genuine second pillar. Even so, the company reckons its total addressable market sits at around 100 million small and medium-sized businesses worldwide, a number that dwarfs its current customer base.
That's where the US comes in. Xero finished FY26 with roughly 424,000 US customers, a fraction of what's on the table in one of management's three priority markets.
The Melio acquisition has strengthened Xero's US proposition by letting businesses manage outgoing payments directly through the platform, and management pegs the US small-business payments opportunity alone at US$29 billion.
If Xero can even chip away at that, the current profit dip starts to look like the cost of buying future growth rather than a red flag.
What are brokers saying?
Opinion is split, but the tone is more optimistic than the share price suggests. Citi has a buy rating on Xero shares with a $113.60 target — nearly 70% above the current price. Morgan Stanley sees $130, and UBS is at $127.
Ord Minnett and Morgans sit more conservatively at $110 and $111. On the cautious end, RBC Capital and Jefferies have targets of $85 and $77 respectively. That's still above where the stock trades today.
Foolish takeaway
Not a single broker target for Xero shares sits below the current share price. That's a striking signal for a stock that's lost more than half its value in a year. The growth numbers, the US opportunity, and now the broker consensus all point the same direction — even if the market hasn't caught up yet.
